A sedative drug used during brain surgery in a patient with severe lung disease
Original title: Dexmedetomidine target-controlled infusion for craniotomy in a patient with brain tumor and giant bullous emphysema.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This describes care given to one person, not a treatment that has been tested and proven.
The short version
This is a report about one patient's brain surgery, and only the title is available.
What was studied. The title describes one patient who had a brain tumor and a severe lung problem called giant bullous emphysema. During surgery to open the skull, the patient was given a sedative drug called dexmedetomidine through a controlled drip.
What they found. No results are available. The full summary of this report was not provided. Only the title could be read, so there are no numbers or findings to share.
What this means, and what it doesn't
What it could mean: For a patient, this is a report about how one person was cared for during surgery. It does not give results you can rely on. Anesthesia choices are made case by case by the surgical team.
What it doesn't mean: This does not mean a new treatment for brain tumors. It is a report about one person, not a study that compared treatments in a group of people. There is no information here about whether this approach helps anyone else. It is not a promise of a cure.
Source: PubMed, August 3, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.